[go: up one dir, main page]

GB202303663D0 - Aerosolisable formulation - Google Patents

Aerosolisable formulation

Info

Publication number
GB202303663D0
GB202303663D0 GBGB2303663.5A GB202303663A GB202303663D0 GB 202303663 D0 GB202303663 D0 GB 202303663D0 GB 202303663 A GB202303663 A GB 202303663A GB 202303663 D0 GB202303663 D0 GB 202303663D0
Authority
GB
United Kingdom
Prior art keywords
aerosolisable formulation
aerosolisable
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2303663.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicoventures Trading Ltd
Original Assignee
Nicoventures Trading Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd
Priority to GBGB2303663.5A priority Critical patent/GB202303663D0/en
Publication of GB202303663D0 publication Critical patent/GB202303663D0/en
Priority to CA3260064A priority patent/CA3260064A1/en
Priority to EP23736448.4A priority patent/EP4543230A1/en
Priority to JP2024573958A priority patent/JP2025520549A/en
Priority to KR1020247042618A priority patent/KR20250016261A/en
Priority to PCT/GB2023/051637 priority patent/WO2023247962A1/en
Pending legal-status Critical Current

Links

GBGB2303663.5A 2022-06-24 2023-03-13 Aerosolisable formulation Pending GB202303663D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB2303663.5A GB202303663D0 (en) 2023-03-13 2023-03-13 Aerosolisable formulation
CA3260064A CA3260064A1 (en) 2022-06-24 2023-06-22 Aerosolisable formulation
EP23736448.4A EP4543230A1 (en) 2022-06-24 2023-06-22 Aerosolisable formulation
JP2024573958A JP2025520549A (en) 2022-06-24 2023-06-22 Aerosolizable Formulations
KR1020247042618A KR20250016261A (en) 2022-06-24 2023-06-22 Aerosolizable formulations
PCT/GB2023/051637 WO2023247962A1 (en) 2022-06-24 2023-06-22 Aerosolisable formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2303663.5A GB202303663D0 (en) 2023-03-13 2023-03-13 Aerosolisable formulation

Publications (1)

Publication Number Publication Date
GB202303663D0 true GB202303663D0 (en) 2023-04-26

Family

ID=86052754

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2303663.5A Pending GB202303663D0 (en) 2022-06-24 2023-03-13 Aerosolisable formulation

Country Status (1)

Country Link
GB (1) GB202303663D0 (en)

Similar Documents

Publication Publication Date Title
GB202007546D0 (en) Formulation
CA3265980A1 (en) Upadacitinib formulation
IL307849A (en) Sotorasib formulation
GB202102636D0 (en) Formulation
IL324083A (en) Maropitant formulation
GB202318884D0 (en) Formulation
GB202316857D0 (en) Cannabinoid-based formulation
CA3265602A1 (en) Aerosolisable formulation
GB202312814D0 (en) Formulation
GB202312220D0 (en) Formulation
CA3261750A1 (en) Formulation
GB202311622D0 (en) Formulation
GB202311439D0 (en) Formulation
IL317857A (en) Orellanine formulation
CA3260064A1 (en) Aerosolisable formulation
GB202308224D0 (en) Formulation
CA3251279A1 (en) Formaldehyde-scavenging formulation
GB202307003D0 (en) Cannabinoid-based formulation
GB202306995D0 (en) Cannabinoid-based formulation
GB202307002D0 (en) Cannabinoid-based formulation
GB202306990D0 (en) Cannabinoid-based formulation
GB202303663D0 (en) Aerosolisable formulation
GB202218160D0 (en) Formulation
GB202217857D0 (en) Formulation
GB202217267D0 (en) Aerosolisable formulation